COO (The Cooper Companies) Total Enterprise Value

Official company branding of CooperSurgical (COO)

The Cooper Companies (COO) develops two autonomous business lines: the production of contact lenses and gynecological instruments. This price chart with the 13776.00 indicator confirms the effectiveness of such a strategy, which offsets market volatility. Business stability is bolstered by maximum automation of production facilities, where robots completely replace humans in the manufacturing process. This balance between high-tech production and the diversification of sales markets guarantees the company's resilience.

COO (coopercos.com) Total Company Value history from 11/23/2025 to 10/28/2026

The Cooper Companies - analytical breakdowns and key metrics (COO)

- price and consensus price forecast:
Market Price The Cooper Companies, Inc.|COO - Price Target Chart
- market capitalization data:
Market Value CooperCompanies|COO - Total Company Value
- book capitalization data:
Net Assets per Share CooperCompanies|COO - Company Book Value|Market Capitalization to Net Assets coopercos.com|COO - Company Total Assets
- debt and liquidity data:
Debt to Capital The Cooper Companies|COO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio coopercos.com|COO - Company Aggregate Debts|Debts to Net Assets CooperCompanies|COO - Company Long-Term Debts|Company Short-Term Debts CooperCompanies
General company analysis:COO (The Cooper Companies, Inc.)
Original product of CooperCompanies

The implementation of ESG standards in the production of ophthalmology products at The Cooper Companies (COO) optimizes resources, enhancing long-term business sustainability. Aggregating market capitalization and net debt allows for an assessment of the actual asset buyout cost, while changes in the EV level neutralize price volatility, demonstrating an objective balance between liquidity and the total enterprise value for a strategic investor.

Who The Cooper Companies competes with

Boston Scientific Corp - Total Enterprise Value|EW (Edwards Lifesciences Corp) - Total Company Value|RMD: Total Enterprise Value|Insulet Corporation - Total Company Value|ZBH (Zimmer Biomet Holdings) - Company Buyout Price|Total Company Value Align Technology ALGN|Full Business Value Globus Medical Inc|TransMedics Group, Inc. - Enterprise Value|Total Enterprise Value Alphatec Corp (ATEC)|Artivion, Inc. - Enterprise Value|Real Price to Acquire Entire Company enovis.com ENOV|Enterprise Value IART (Integra LifeSciences Holdings Corporation)|ESTA - Company Buyout Price|BBNX: Enterprise Value|IRMD (IRADIMED Inc.) - Enterprise Value|Total Company Value Embecta Corp.|Total Company Value tandemdiabetes.com|AXGN (Axogen) - Enterprise Value|Company Buyout Price SI-BONE Inc SIBN|Orthofix International (OFIX) - Real Price to Acquire Entire Company|Full Business Value Bioventus Global BVS|KIDS (OrthoPediatrics Inc.) - Enterprise Value|TMCI - Total Enterprise Value|Enterprise Value Strata Critical Medical|Business Value Carlsmed, Inc.|RXST - Real Price to Acquire Entire Company|Value Adjusted for Debt and Cash CLPT|Total Company Value STXS (Stereotaxis, Inc.)|Real Price to Acquire Entire Company neurostar.com (STIM)|SGHT: Enterprise Value|Total Enterprise Value orchestrabiomed.com OBIO|Anika (ANIK) - Enterprise Value|NSPR - Business Value|zhjmedical.com - Enterprise Value|Vivani Medical (VANI) - Company Buyout Price|Enterprise Value XTNT|Real Price to Acquire Entire Company NeuroOne|Enterprise Value MODD|Enterprise Value MYO (Myomo Inc)|Total Company Value Envoy Medical, Inc. COCH|VVOS - Total Company Value|Real Price to Acquire Entire Company enVVeno Medical Corp. (NVNO)|SINT - Value Adjusted for Debt and Cash|Enterprise Value TNON|LFWD (Lifeward Ltd.) - Total Enterprise Value|Autonomix Medical Inc. - Total Company Value|Full Takeover Company Value invobioscience.com (IVF)|Real Price to Acquire Entire Company BBLG|Enterprise Value Axonics Inc. (AXNX)|Enterprise Value BIOL|Dynatronics Corp - Company Buyout Price|Total Company Value Paragon 28 Corp|INVO: Full Business Value